Roy Winston, Chief Clinical Officer at Pacira BioSciences, Inc. (PCRX), sold 722 shares at $42.91 ($31K) on 2019-06-04, disclosed to the SEC on 2019-06-06.
Open-market sale of $31k PCRX by Chief Clinical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCRX | SELL | 2022-08-05 | $27K | — | Filing → |
| PCRX | SELL | 2022-06-08 | $1.9M | — | Filing → |
| PCRX | SELL | 2021-06-08 | $278K | — | Filing → |